MGX Metagenomi Therapeutics, Inc. - Common Stock
$1,22
Precio · Ago 18, 2026
Fundamentales a fecha de Ago 10, 2026
Rango 52S
$1–$4
3% of range
Calificación del Analista
BUY
9 analysts
Precio Objetivo
$7
+474% upside
P/E (TTM)
-0.5
ROE
-49.6%
Margen de Beneficio Neto
-348.5%
MGX Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$1.22
Capitalización Bursátil
$46M
P/E (TTM)
-0.5
BPA (TTM)
$-2.36
Ingresos (TTM)
$25M
Rendimiento div.
—
ROE
-49.6%
Deuda/Capital
—
Rango 52S
$1 – $4
MGX Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$25M
2023-12-31
→
2025-12-31
BPA
$-2.36
2023-12-31
→
2025-12-31
Flujo de caja libre
$-89M
2024-12-31
→
2025-12-31
Márgenes
-348.5%
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
MGX
Mediana de Pares
P/E (TTM)
-0.5
—
P/S (TTM) (P/V (TTM))
1.8
4.1
P/B (P/C)
0.3
1.4
Price / FCF (Precio / FCF)
-0.5
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
MGX
Mediana de Pares
Operating Margin (Margen Operativo)
-380.9%
—
Net Profit Margin (Margen de Beneficio Neto)
-348.5%
-702.6%
ROA
-32.2%
-101.8%
ROE
-49.6%
-136.1%
ROIC
-60.5%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
MGX
Mediana de Pares
Current Ratio (Ratio corriente)
7.2
3.0
Quick Ratio (Ratio Rápido)
1.8
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
MGX
Mediana de Pares
Revenue YoY (Ingresos interanuales)
-51.8%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
MGX
Mediana de Pares
MGX Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
9 analistas
- Compra fuerte 2 22,2%
- Compra 5 55,6%
- Mantener 2 22,2%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
3 analistas · 2026-08-15
Mediana
$7.00
← Por Debajo de Todos los Objetivos
$1.22
Mín
$5.00
Máx
$9.00
Objetivo mediano
$7.00
+473,8%
Objetivo medio
$7.00
+473,8%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-0.01%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 31 de marzo de 2026 | $-0.61 | $-0.53 | -0.08% |
| 31 de diciembre de 2025 | $-0.60 | $-0.61 | 0.01% |
| 30 de septiembre de 2025 | $-0.55 | $-0.59 | 0.04% |
| 30 de junio de 2025 | $-0.54 | $-0.63 | 0.09% |
| 31 de marzo de 2025 | $-0.68 | $-0.58 | -0.10% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| MGX | $61M | -0.7 | -51.8% | -348.5% | -49.6% | — |
| ATYR | $77M | -1.0 | -19.1% | -39009.5% | -107.8% | — |
| TIL | $75M | -1.0 | — | — | -58.1% | — |
| MCRB | $142M | 23.2 | — | 721.9% | 14.8% | — |
| KPTI | $135M | -0.4 | 0.57% | -134.2% | 73.7% | — |
| TVGN | — | — | — | — | — | — |
| ELUT | — | 0.8 | -15.0% | 434.2% | -753.4% | 53.7% |
| ALGS | $58M | -3.8 | -39.5% | -1106.7% | -31.1% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 15
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $25M | $52M | $45M | |
| R&D Expense | $94M | $109M | $94M | |
| SG&A Expense | $27M | $32M | $29M | |
| Operating Expenses | $121M | $141M | $123M | |
| Operating Income | $-96M | $-89M | $-78M | |
| Interest Income | $9M | $15M | $15M | |
| Other Non-op | $-91.0K | $-207.0K | $-74.0K | |
| Pretax Income | $-88M | $-84M | $-60M | |
| Income Tax | $-58.0K | $-6M | $8M | |
| Net Income | $-88M | $-78M | $-68M | |
| EPS (Basic) | $-2.36 | $-2.36 | $-20.05 | |
| EPS (Diluted) | $-2.36 | $-2.36 | $-20.05 | |
| Shares (Basic) | 37,251,050 | 33,027,889 | 3,404,585 | |
| Shares (Diluted) | 37,251,050 | 33,027,889 | 3,404,585 | |
| EBITDA | $-96M | $-89M | · |
Balance general 21
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $42M | $27M | $141M | |
| Receivables | $305.0K | $1M | $2M | |
| Prepaid Expense | $4M | $8M | $5M | |
| Current Assets | $166M | $258M | $278M | |
| PP&E (Net) | $12M | $18M | $22M | |
| PP&E (Gross) | $28M | $29M | $28M | |
| Accum. Depreciation | $16M | $11M | $6M | |
| Other Non-current Assets | $836.0K | $287.0K | $5M | |
| Total Assets | $221M | $325M | $365M | |
| Accounts Payable | $1M | $533.0K | $2M | |
| Current Liabilities | $23M | $37M | $69M | |
| Capital Leases | $35M | $40M | $45M | |
| Other Non-current Liabilities | $2M | $2M | $5M | |
| Total Liabilities | $63M | $90M | $150M | |
| Common Stock | $4.0K | $4.0K | $0 | |
| Paid-in Capital | $469M | $457M | $9M | |
| Retained Earnings | $-311M | $-223M | $-145M | |
| AOCI | $260.0K | $709.0K | $-97.0K | |
| Stockholders' Equity | $159M | $235M | $-136M | |
| Liabilities + Equity | $221M | $325M | $365M | |
| Shares Outstanding | 37,620,668 | 37,418,470 | 3,404,585 |
Flujo de Efectivo 8
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $12M | $16M | $7M | |
| Operating Cash Flow | $-89M | $-109M | $-91M | |
| CapEx | $574.0K | $3M | $10M | |
| Investing Cash Flow | $104M | $-88M | $46M | |
| Financing Cash Flow | $-356.0K | $84M | $1M | |
| Net Change in Cash | $14M | $-113M | $-45M | |
| Taxes Paid | $-2M | $4M | $2M | |
| Free Cash Flow | $-89M | $-112M | · |
Rentabilidad 7
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | -380.9% | -170.0% | · | |
| Net Margin | -348.5% | -149.3% | · | |
| Pretax Margin | -348.8% | -159.8% | · | |
| EBITDA Margin | -380.9% | -170.0% | · | |
| ROA | -32.2% | -22.6% | · | |
| ROE | -49.6% | -31.8% | · | |
| ROIC | -60.5% | -35.4% | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 7.2 | 6.9 | · | |
| Quick Ratio | 1.8 | 0.8 | · |
Eficiencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.2 | · | |
| Receivables Turnover | 32.3 | 28.2 | · |
Tasas de Crecimiento 1
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | -51.8% | 16.8% | · |
Valoración (TTM) 10
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $25M | $52M | $45M | |
| Net Income TTM | $-88M | $-78M | $-68M | |
| Market Cap | $61M | $135M | · | |
| P/E | -0.7 | -1.5 | · | |
| P/S | 2.4 | 2.6 | · | |
| P/B | 0.4 | 0.6 | · | |
| P / Tangible Book | 0.4 | 0.6 | · | |
| P / Cash Flow | -0.7 | -1.2 | · | |
| P / FCF | -0.7 | -1.2 | · | |
| Earnings Yield | -145.7% | -65.4% | · |
Estado de resultados 15
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | $1M | $4M | $9M | $9M | $4M | $10M | $12M | $20M | $11M | $12M | $12M | $11M | $9M | |
| R&D Expense | $23M | $19M | $22M | $25M | $23M | $25M | $23M | $26M | $28M | $31M | $25M | $27M | $23M | $20M | |
| SG&A Expense | $6M | $7M | $7M | $6M | $7M | $7M | $7M | $8M | $9M | $9M | $8M | $8M | $7M | $6M | |
| Operating Expenses | $29M | $26M | $28M | $31M | $30M | $32M | $30M | $34M | $37M | $40M | $33M | $35M | $29M | $27M | |
| Operating Income | $-29M | $-25M | $-24M | $-23M | $-21M | $-28M | $-21M | $-22M | $-17M | $-29M | $-20M | $-22M | $-18M | $-18M | |
| Interest Income | $1M | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Other Non-op | $35.0K | $-1.0K | $-11.0K | $-2.0K | $-70.0K | $-8.0K | $-49.0K | $-57.0K | $-51.0K | $-50.0K | $-4.0K | $-85.0K | $16.0K | $-1.0K | |
| Pretax Income | $-27M | $-23M | $-22M | $-21M | $-20M | $-25M | $-25M | $-21M | $-13M | $-25M | $-17M | $-19M | $-11M | $-14M | |
| Income Tax | $0 | $10.0K | $34.0K | $-234.0K | $44.0K | $98.0K | $-1M | $-2M | $-2M | $0 | $7M | $1M | $2M | $-2M | |
| Net Income | $-27M | $-23M | $-23M | $-20M | $-20M | $-25M | $-23M | $-19M | $-11M | $-25M | $-19M | $-20M | $-13M | $-16M | |
| EPS (Basic) | $-0.73 | $-0.61 | $-0.59 | $-0.55 | $-0.54 | $-0.68 | $-0.37 | $-0.51 | $-0.29 | $-1.19 | $-5.67 | $-5.82 | $-3.82 | $-4.74 | |
| EPS (Diluted) | $-0.73 | $-0.61 | $-0.59 | $-0.55 | $-0.54 | $-0.68 | $-0.37 | $-0.51 | $-0.29 | $-1.19 | $-5.67 | $-5.82 | $-3.82 | $-4.74 | |
| Shares (Basic) | 37,658,250 | 37,581,094 | -74,274,405 | 37,349,449 | 37,156,979 | 37,019,027 | -61,501,579 | 36,766,309 | 36,625,291 | 21,137,868 | -6,809,170 | 3,404,585 | 3,404,585 | 3,404,585 | |
| Shares (Diluted) | 37,658,250 | 37,581,094 | -74,274,405 | 37,349,449 | 37,156,979 | 37,019,027 | -61,501,579 | 36,766,309 | 36,625,291 | 21,137,868 | -6,809,170 | 3,404,585 | 3,404,585 | 3,404,585 | |
| EBITDA | $-29M | $-25M | · | $-23M | $-21M | $-28M | · | $-22M | $-17M | $-29M | · | · | · | · |
Balance general 21
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $39M | $25M | $42M | $33M | $27M | $29M | $27M | $25M | $61M | $103M | $141M | · | · | · | |
| Receivables | $0 | $0 | $305.0K | $960.0K | $900.0K | $900.0K | $1M | $589.0K | $2M | $2M | $2M | · | · | · | |
| Prepaid Expense | $4M | $4M | $4M | $5M | $6M | $6M | $8M | $7M | $6M | $6M | $5M | · | · | · | |
| Current Assets | $124M | $145M | $166M | $190M | $212M | $233M | $258M | $282M | $308M | $336M | $278M | · | · | · | |
| PP&E (Net) | $10M | $11M | $12M | $14M | $15M | $17M | $18M | $20M | $21M | $21M | $22M | · | · | · | |
| PP&E (Gross) | · | · | $28M | · | · | · | $29M | · | · | · | $28M | · | · | · | |
| Accum. Depreciation | · | · | $16M | · | · | · | $11M | · | · | · | $6M | · | · | · | |
| Other Non-current Assets | $1M | $927.0K | $836.0K | $809.0K | $805.0K | $781.0K | $287.0K | $320.0K | $332.0K | $379.0K | $5M | · | · | · | |
| Total Assets | $174M | $197M | $221M | $248M | $272M | $298M | $325M | $358M | $386M | $415M | $365M | · | · | · | |
| Accounts Payable | $3M | $2M | $1M | $1M | $3M | $3M | $533.0K | $3M | $3M | $7M | $2M | · | · | · | |
| Current Liabilities | $28M | $22M | $23M | $30M | $33M | $40M | $37M | $46M | $53M | $71M | $69M | · | · | · | |
| Capital Leases | $31M | $33M | $35M | $36M | $37M | $39M | $40M | $41M | $43M | $44M | $45M | · | · | · | |
| Other Non-current Liabilities | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $4M | $5M | $5M | · | · | · | |
| Total Liabilities | $61M | $59M | $63M | $69M | $76M | $85M | $90M | $103M | $116M | $140M | $150M | · | · | · | |
| Common Stock | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $0 | · | · | · | |
| Paid-in Capital | $474M | $472M | $469M | $466M | $463M | $460M | $457M | $454M | $451M | $446M | $9M | · | · | · | |
| Retained Earnings | $-361M | $-334M | $-311M | $-288M | $-268M | $-248M | $-223M | $-200M | $-181M | $-170M | $-145M | · | · | · | |
| AOCI | $-122.0K | $-44.0K | $260.0K | $371.0K | $372.0K | $621.0K | $709.0K | $2M | $-265.0K | $-278.0K | $-97.0K | · | · | · | |
| Stockholders' Equity | $113M | $138M | $159M | $178M | $196M | $213M | $235M | $256M | $269M | $276M | $-136M | · | · | · | |
| Liabilities + Equity | $174M | $197M | $221M | $248M | $272M | $298M | $325M | $358M | $386M | $415M | $365M | · | · | · | |
| Shares Outstanding | 37,777,105 | 37,647,057 | 37,620,668 | 37,546,751 | 37,533,136 | 37,382,478 | 37,418,470 | 37,432,832 | 37,459,853 | 37,468,078 | 3,404,585 | · | · | · |
Flujo de Efectivo 7
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $5M | $5M | $2M | $3M | $656.0K | $529.0K | |
| Operating Cash Flow | $-20M | $-21M | $-24M | $-21M | $-21M | $-23M | $-26M | $-27M | $-26M | $-30M | $-21M | $-24M | $-26M | $-21M | |
| CapEx | $125.0K | $25.0K | $85.0K | $74.0K | $127.0K | $288.0K | $334.0K | $1M | $665.0K | $915.0K | $2M | $2M | $3M | $3M | |
| Investing Cash Flow | $33M | $4M | $32M | $27M | $19M | $25M | $29M | $-9M | $-13M | $-95M | $61M | $76M | $-19M | $-72M | |
| Financing Cash Flow | $67.0K | $-27.0K | $74.0K | $-187.0K | $-166.0K | $-77.0K | $0 | $-492.0K | $-2M | $87M | $-1M | $-2M | $-39.0K | $4M | |
| Net Change in Cash | $14M | $-17M | $9M | $6M | $-2M | $2M | $2M | $-36M | $-41M | $-38M | $39M | $50M | $-45M | $-89M | |
| Free Cash Flow | · | $-21M | · | · | · | $-23M | · | · | · | $-31M | · | · | · | · |
Rentabilidad 7
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -1970.1% | · | -263.8% | -246.5% | -674.1% | · | -194.4% | -84.3% | -260.2% | · | · | · | · | |
| Net Margin | · | -1847.7% | · | -235.5% | -233.8% | -606.7% | · | -163.0% | -53.7% | -225.4% | · | · | · | · | |
| Pretax Margin | · | -1846.9% | · | -238.2% | -233.3% | -604.3% | · | -181.3% | -64.7% | -225.4% | · | · | · | · | |
| EBITDA Margin | · | -1970.1% | · | -263.8% | -246.5% | -674.1% | · | -194.4% | -84.3% | -260.2% | · | · | · | · | |
| ROA | -12.3% | -9.3% | · | -6.7% | -6.0% | -7.0% | · | -10.5% | -5.6% | -12.1% | · | · | · | · | |
| ROE | -17.8% | -13.2% | · | -9.4% | -8.6% | -10.3% | · | -14.7% | -8.0% | -18.2% | · | · | · | · | |
| ROIC | -25.6% | -17.8% | · | -12.7% | -10.7% | -13.1% | · | -7.9% | -5.2% | -10.5% | · | · | · | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 6.4 | · | 6.4 | 6.4 | 5.8 | · | 6.2 | 5.8 | 4.7 | · | · | · | · | |
| Quick Ratio | 1.4 | 1.1 | · | 1.1 | 0.8 | 0.8 | · | 0.6 | 1.2 | 1.5 | · | · | · | · |
Eficiencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | · | · | · | |
| Receivables Turnover | · | 2.8 | · | 11.2 | 6.7 | 2.8 | · | 39.1 | 24.3 | 10.7 | · | · | · | · |
Valoración (TTM) 10
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $23M | $23M | · | $33M | $44M | $47M | · | $55M | $55M | $44M | · | · | · | · | |
| Net Income TTM | $-91M | $-88M | · | $-84M | $-74M | $-80M | · | $-74M | $-69M | $-74M | · | · | · | · | |
| Market Cap | $45M | $50M | · | $89M | $56M | $51M | · | $81M | $153M | $395M | · | · | · | · | |
| P/E | -0.5 | -0.6 | · | -1.0 | -0.7 | -0.5 | · | -0.3 | -0.4 | -0.7 | · | · | · | · | |
| P/S | 2.0 | 2.2 | · | 2.7 | 1.3 | 1.1 | · | 1.5 | 2.8 | 9.1 | · | · | · | · | |
| P/B | 0.4 | 0.4 | · | 0.5 | 0.3 | 0.2 | · | 0.3 | 0.6 | 1.4 | · | · | · | · | |
| P / Tangible Book | 0.4 | 0.4 | · | 0.5 | 0.3 | 0.2 | · | 0.3 | 0.6 | 1.4 | · | · | · | · | |
| P / Cash Flow | · | -2.4 | · | · | · | -2.2 | · | · | · | -13.2 | · | · | · | · | |
| P / FCF | · | -2.4 | · | · | · | -2.2 | · | · | · | -12.8 | · | · | · | · | |
| Earnings Yield | -204.2% | -177.6% | · | -96.2% | -136.5% | -196.3% | · | -359.9% | -272.5% | -147.6% | · | · | · | · |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Ingresos | $25M | $52M | $45M |
| Margen Operativo % | -380.9% | -170.0% | — |
| Beneficio neto | $-88M | $-78M | $-68M |
| EPS Diluido | $-2.36 | $-2.36 | $-20.05 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Ratio corriente | 7.2 | 6.9 | — |
| Ratio Rápido | 1.8 | 0.8 | — |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Flujo de caja libre | $-89M | $-112M | — |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 52 declarantes · $10.9M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 7 (+5 vs trimestre anterior) | 8 (-3 vs trimestre anterior) | 10 (-2 vs trimestre anterior) | 12 (-1 vs trimestre anterior) | +1.1M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $1 760 422 | 1 086 680 | 16,16% | Acciones |
| Sozo Ventures GP II, L.P. | $1 331 404 | 581 577 | 12,22% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $1 282 463 | 1 077 700 | 11,77% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $883 456 | 742 400 | 8,11% | Acciones |
| Catalio Capital Management, LP | $629 502 | 528 993 | 5,78% | Acciones |
| Peapod Lane Capital LLC | $624 779 | 525 024 | 5,73% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $611 304 | 513 701 | 5,61% | Acciones |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $476 357 | 400 300 | 4,37% | Acciones |
| WELLS FARGO & COMPANY/MN | $421 538 | 354 234 | 3,87% | Acciones |
| TWO SIGMA ADVISERS, LP | $326 106 | 201 300 | 2,99% | Acciones |
| PURA VIDA INVESTMENTS, LLC | $314 625 | 264 391 | 2,89% | Acciones |
| Good Life Advisors, LLC | $296 000 | 200 000 | 2,72% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $278 501 | 233 899 | 2,56% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $203 789 | 171 251 | 1,87% | Acciones |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $190 400 | 160 000 | 1,75% | Acciones |
| STATE STREET CORP | $142 622 | 119 850 | 1,31% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $135 690 | 114 025 | 1,25% | Acciones |
| Man Group plc | $129 865 | 109 130 | 1,19% | Acciones |
| Resolute Advisors LLC | $107 033 | 89 944 | 0,98% | Acciones |
| Nuveen Asset Management, LLC | $100 181 | 27 751 | 0,92% | Acciones |
| Marquette Asset Management, LLC | $85 824 | 72 121 | 0,79% | Acciones |
| NORTHERN TRUST CORP | $82 036 | 68 938 | 0,75% | Acciones |
| RBF Capital, LLC | $76 185 | 64 021 | 0,70% | Acciones |
| XTX Topco Ltd | $66 291 | 55 707 | 0,61% | Acciones |
| BBR PARTNERS, LLC | $63 550 | 53 403 | 0,58% | Acciones |
| Fortitude Advisory Group L.L.C. | $44 256 | 37 190 | 0,41% | Acciones |
| JANE STREET GROUP, LLC | $41 769 | 35 100 | 0,38% | Acciones |
| CITADEL ADVISORS LLC | $21 243 | 17 851 | 0,19% | Acciones |
| Qube Research & Technologies Ltd | $20 052 | 16 850 | 0,18% | Acciones |
| UBS Group AG | $18 794 | 15 793 | 0,17% | Acciones |
| TWO SIGMA SECURITIES, LLC | $18 056 | 15 173 | 0,17% | Acciones |
| Cubist Systematic Strategies, LLC | $17 682 | 7 461 | 0,16% | Acciones |
| Vanguard Global Advisers, LLC | $15 936 | 13 392 | 0,15% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $15 228 | 12 797 | 0,14% | Acciones |
| Peak Planning Group, LLC | $14 875 | 12 500 | 0,14% | Acciones |
| Point72 Asia (Singapore) Pte. Ltd. | $11 665 | 4 922 | 0,11% | Acciones |
| BlackRock, Inc. | $8 190 | 6 882 | 0,08% | Acciones |
| MEEDER ASSET MANAGEMENT INC | $6 540 | 5 496 | 0,06% | Acciones |
| Tower Research Capital LLC (TRC) | $6 307 | 5 300 | 0,06% | Acciones |
| US BANCORP \DE\ | $5 355 | 4 500 | 0,05% | Acciones |
| MORGAN STANLEY | $5 019 | 4 218 | 0,05% | Acciones |
| OSAIC HOLDINGS, INC. | $2 250 | 1 891 | 0,02% | Acciones |
| FMR LLC | $700 | 588 | 0,01% | Acciones |
| JONES FINANCIAL COMPANIES LLLP | $625 | 500 | 0,01% | Acciones |
| Allworth Financial LP | $595 | 500 | 0,01% | Acciones |
| Point72 (DIFC) Ltd | $318 | 134 | 0,00% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $246 | 207 | 0,00% | Acciones |
| BARCLAYS PLC | $199 | 167 | 0,00% | Acciones |
| JPMORGAN CHASE & CO | $151 | 126 | 0,00% | Acciones |
| CWM, LLC | $34 | 25 | 0,00% | Acciones |
| Caitong International Asset Management Co., Ltd | $10 | 8 | 0,00% | Acciones |
| Optiver Holding B.V. | $2 | 2 | 0,00% | Acciones |
Informantes de la empresa 14 insiders · 7 directivos · 7 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Jian Irish | President and Chief Executive Officer | 5 de junio de 2026 S | 377 533 | 0 | 4 | $-13 165 |
| Pamela Wapnick | Chief Financial Officer | 5 de junio de 2026 S | 208 491 | 0 | 4 | $-11 922 |
| Matthew Wein | Title: General Counsel, Compliance Officer and Corporate Secretary | 5 de junio de 2026 S | 126 491 | 0 | 4 | $-2 208 |
| Sarah B. Noonberg | Chief Medical Officer | 6 de junio de 2025 S | 109 135 | 0 | 0 | $0 |
| Simren Delaney | Title: Vice President of Intellectual Property and Legal Operations | 1 de abril de 2024 A | 93 892 | 0 | 0 | $0 |
| Simon Harnest | Title: Chief Investment Officer and Senior Vice President of Strategy | 1 de abril de 2024 A | 122 664 | 0 | 0 | $0 |
| Luis Borges | Chief Scientific Officer | 1 de abril de 2024 A | 69 316 | 0 | 0 | $0 |
| Juergen Eckhardt | Consejero | 9 de junio de 2026 A | — | 0 | 0 | $0 |
| Laurence Reid | Consejero | 9 de junio de 2026 A | — | 0 | 0 | $0 |
| Willard H Dere | Consejero | 9 de junio de 2026 A | — | 0 | 0 | $0 |
| Eric Bjerkholt | Consejero | 9 de junio de 2026 A | — | 0 | 0 | $0 |
| Brian C. Thomas | Consejero | 5 de diciembre de 2025 S | 2 510 960 | 0 | 2 | $-11 668 |
| Sebastian Bernales | Consejero | 1 de abril de 2024 A | 1 896 445 | 0 | 0 | $0 |
| Novo Holdings A/S | Propietario del 10% | 13 de febrero de 2024 C | 1 739 175 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 4 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| ISCF · iShares Trust | 0,07% | 1 807 801 SH | 8 de agosto de 2026 | Diario |
| IWC · iShares Trust | 0,01% | 95 479 SH | 8 de agosto de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 315 460 SH | 8 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 741 407 SH | 8 de agosto de 2026 | Diario |